Skip to content
Recall Observatory FDA recall evidence

Drug product

MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons.

D-0370-2022

December 31, 2021

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 89326
Status
Terminated
Classification
Class II
Quantity
7,400 cartons
Official record key
drug-enforcement:D-0370-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot # 100022393, exp 09/2022

Distribution pattern: Methylprednisolone, TN Norepinephrine BItartrate - MS, OH

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility